Purchase Order N6264520P0020
Award Date 4/16/20
Potential Completion Date 4/15/25
Potential Value $3.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This...
- On October 1, 2020, the Defense Health Agency awarded Biofire Diagnostics LLC a firm fixed-price purchase order valued at approximately $4.5 million for the provision of respiratory, gastrointestinal, meningitis, and blood culture identification assay panels to the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract, which has no set-aside designation, extends through September 30, 2025, and includes adjustments in reagent...
- The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
- <p>The Defense Health Agency awarded a purchase order to Biofire Defense LLC for $4.65 million on April 15, 2026, for a molecular assay analyzer cost per test to include reagents, maintenance, and consumables, with a ceiling value of $4,651,935.82 and an ultimate completion date of April 14, 2031. The order is firm fixed price with no set-aside designation. Work is performed in Millcreek, Utah.</p>
- The Defense Health Agency (DOD) awarded a $742,431.36 firm fixed price purchase order to Biofire Defense LLC of Salt Lake City, Utah. The contract is to provide Respiratory Panel 2.1 In Vitro Diagnostic tests from November 7, 2022 through January 11, 2023. Biofire Defense LLC will deliver their Biofire Respiratory Panel 2.1 tests, which can rapidly detect more than twenty common respiratory pathogens including influenza A and B, respiratory syncytial virus, rhinovirus/enterovirus, coronavirus...
- This firm-fixed-price purchase order was awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the delivery of Biofire FilmArray 2.0 complete systems, a molecular diagnostic technology used for rapid pathogen detection and infectious disease testing. The contract has a ceiling value of $39,206.77 and a period of performance ending on April 24, 2020. This contract award is...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...
- This federal contract award is for the purchase of a BIOFIRE ANALYZER from Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The $8,000.00 firm fixed-price purchase order was awarded on November 4, 2021 by the Defense Health Agency, an alternate name for the Defense Department's Defense Health Agency. The award has an ultimate completion date of January 2, 2022 and does not have a set-aside designation. Biofire Defense LLC is a manufacturer of specialized...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the delivery of 8 FilmArray Torch Module Boxes and 4 FilmArray Torch Duplex Module Boxes. The $168,000 contract was awarded on June 23, 2020 with a completion date of September 23, 2020. The purchase is associated with the Coronavirus COVID-19 National Interest Action Code. Biofire Diagnostics LLC is a biotech company that...